not to interfere with the binding measurements.
Concentration of proteins was measured by absorbance spectroscopy (Swi6: ε 280 = 41,035 M -1 cm -1 , Chp1 CDs: ε 280 = 29,450 M -1 cm -1 , Clr4 CD: ε 280 = 20,970 M -1 cm -1 ,). Peptide concentrations were determined using absorbance spectroscopy (extinction coefficient for tyrosine, ε 280 = 1280 M -1 cm -1 ; extinction coefficient for fluoresceinated peptides ε 492 = 68,000 M -1 cm -1 ). Binding curves were analyzed using the scipy module of the python programming language. Data was analyzed as described (Jacobs et al. 2003) , except that a bimodal equation to account for non-specific binding at high protein concentrations was used when the data displayed clear bimodal behavior: With x being the protein concentration, A 0 the anisotropy of the free peptide, A s the anisotropy of the specifically bound peptide and A ns the anisotropy of the non-specifically bound peptide. K ds represents the specific dissociation constant and K dns the non-specific dissociation constant.
Isothermal Titration Calorimetry
Isothermal titration calorimetry was performed on a VP-ITC instrument (MicroCal). Chromodomain proteins and peptides (same sequence as for FP, but without label) were dialyzed overnight against 50 mM KPO 4 pH 7.0, 25 mM NaCl, 1 mM DTT. Exothermic heats of reaction (μcal/s) were measured for 30 injections of the H3 peptides (250 μM), each 10μl, spaced at 4 min intervals, into 1.41 ml of 25 μM chromodomain protein. Binding curves were analyzed by non-linear least squares fitting of the data using the Origin (MicroCal) software package.
Crystal structure determination
Data were collected under cryo conditions at the National Synchrotron Light Source (NSLS) beam line X29 using a wavelength of 1.0809 Å. Phases were obtained by molecular replacement using the HP1 chromodomain (Jacobs et al. 2002) excluding the peptide (chain A of PDB entry 1KNE) as a search model. The structure was built in coot (Emsley et al. 2004 ) and refined with phenix.refine (Adams et al. 2002 ). The final model shows Ramachandran statistics of 90.7% of all residues in most favored and 9.3% in additionally allowed regions as calculated by Procheck. Coordinates can be accessed under PDB code 3G7L.
We observed a crucial crystal contact mediated by zinc ions that are coordinated by a total of four aspartates; D48 and D51 from two separate molecules related by crystallographic symmetry. These residues were simultaneously mutated to serine to investigate a potential role for the zinc binding motif. The recombinant chromodomain for this mutant was completely insoluble, and therefore an affinity could not be determined for this mutant.
Strain construction.
Mutagenesis of the Chp1 chromodomain was performed by homologous recombination to replace the ura4 marker in PY 282 (CDΔ::ura4 + chp1-6xmyc (Petrie et al. 2005) ) with a chimeric PCR product consisting of the chromodomain point mutant of interest. Strains were selected on FOA medium, and PCR and DNA sequencing were used to confirm the generation of the mutant chp1-6xmyc strains after two outcrosses. Strains were outcrossed again to introduce the centromeric ura4 + marker at otr1R(Sph1) and the ura4 minigene (ura4 DS/E) at the endogenous ura4 locus. The Chp1 chromodomain series was similarly generated in strains lacking the C terminal 6xmyc tag on Chp1.
For these strains, ura4 was used to replace the chromodomain of Chp1 in PY42 (generating PY 3054), and following generation of the Chp1 point mutants, strains were outcrossed twice with PY90 prior to outcrossing with PY189 and reverification of the mutation by sequencing. Py 905 h+ otr1R Sph1::ura4 ura4DS/E chp1::E23V,V24Mchp1-6xmyc-LEU2 ade6-210 leu1-32
Py 3166 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::V24Rchp1-6xmyc-LEU2 ade6-210 leu1-32
Py 3129 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::V21Achp1-6xmyc-LEU2 ade6-210 leu1-32
Py 3188 h? otr1R (Sph1)::ura4 ura4-DS/E chp1::F61Achp1-6xmyc-LEU2 ade6-210 leu1-32
Py 3132 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::D48S,D51Schp1-6xmyc-LEU2 ade6-210 leu1-32
Py 3462 h? otr1R (Sph1)::ura4 ura4DS/E chp1::chp1 aa1-8 Swi6CD aa68-132 chp1 aa71-960 -6xmyc-LEU2 ade6-210 leu1-32 arg3D? his3D? Fig. 3B, 3C , 4A,4B,4C, S3,S4,S5,S6 ,S7
Py 42 h-ura4-D18 ade6-210 leu1-32 arg3D his3D
Py 189 h-chp1::chp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D
Py 1798 h-clr4Δ::KanR ura4D18 or DS/E ade6-210 leu1-32 arg3D his3D
PY 90 h-chp1Δ::his3+ ura4DS/E ade6-210 leu1-32 his3+
Py 386 h-chp1::chp1-CDΔ-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D
Py 3107 h-chp1::V24Rchp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D
Py 631 h-chp1::N59Achp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32
Py 630 h-chp1::V24Mchp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32
Py 760 h-chp1::E23Vchp1-6xmyc-LEU2 ura4DS/E ade6-210 leu1-32 arg3D his3D
Py 1681 h-chp1::E23V,V24Mchp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D
Py 3086 h-chp1::V21Achp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D
Py 3141 h-chp1::F61A chp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D
Py 3091 h-chp1::D48S,D51Schp1-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D
Py 3393 h-chp1::chp1 aa1-8 Swi6CD aa68-132 chp1 aa71-960 -6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D h-otr1R (Sph1)::ura4 ura4-DS/E ago1::F276Aago1-KanR chp1::E23Vchp1 ade6-210 leu1-32
Py 3535 h-otr1R (Sph1)::ura4 ura4DS/E chp1::F61Achp1 ade6-210 leu1-32 arg3D his3D
Py 3921 h+ otr1R (Sph1)::ura4 ura4DS/E ago1::F276Aago1-KanR chp1::F61Achp1 ade6-210, leu1-32 Fig. 5, 6A , 6B, S9,S10
Py 2036 h-otr1R (Sph1)::ura4 ura4-DS/E ade6-210 leu1-32
Py 1838 h-otr1R (Sph1)::ura4 ura4DS/E clr4Δ::KanR ade6-210 leu1-32 his3D
Py 3417 h-otr1R (Sph1)::ura4 ura4-DS/E JP1084 his3+ genomic Clr4 (HpaI)::clr4Δ::KanR ade6-210 leu1-32 his3D
Py 3413 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::V24Mchp1 JP1084 his3+ genomic Clr4 (HpaI)::clr4Δ::KanR ade6-210 leu1-32 his3D
Py 3409 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::E23Vchp1 JP1084 his3+ genomic Clr4 (HpaI)::clr4Δ::KanR ade6-210 leu1-32 his3D
Py 3429 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::N59Achp1 JP1084 his3+ genomic Clr4 (HpaI)::clr4Δ::KanR ade6-210 leu1-32 his3D
Py 3421 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::F61Achp1 JP1084 his3+ genomic Clr4 (HpaI)::clr4Δ::KanR ade6-210 leu1-32 his3D
Py 3401 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::D48S,D51Schp1 JP1084 his3+ genomic Clr4 (HpaI)::clr4Δ::KanR ade6-210 leu1-32 his3D
Py 3425 h-otr1R (Sph1)::ura4 ura4-DS/E chp1::chp1 aa1-8 Swi6CD aa68-132 chp1 aa71-960 JP1084 his3+ genomic Clr4 (HpaI)::clr4Δ::KanR ade6-210 leu1-32 his3D Py 3497 h-otr1R Sph1::ura4 ura4-DS/E tas3::tas3 W265A,G266A-TAP-KanR ade6-210 leu1-32 arg3D? his3D
Py 4057 h-otr1R Sph1::ura4 ura4-DS/E chp1::E23Vchp1 tas3::tas3-TAP-KanR ade6-210 leu1-32 his3D?
Py 4058 h-otr1R Sph1::ura4 ura4-DS/E chp1::N59Achp1 tas3::tas3-TAP-KanR ade6-210 leu1-32 his3D arg3?
Py 4062 h-otr1R Sph1::ura4 ura4-DS/E chp1::E23Vchp1 tas3::tas3 W265A,G266A-TAP-KanR ade6-210 leu1-32 his3?
Py 4064 h-otr1R Sph1::ura4 ura4-DS/E chp1::N59Achp1 tas3::tas3 W265A,G266A-TAP-KanR ade6-210 leu1-32 his3D arg3? PY1402 h-otr1R Sph1::ura4 ura4-DS/E tas3::KanR ade6-210 leu1-32 methods Py 282 h-chp1::chp1CDΔ::ura4+-6xmyc-LEU2 ura4D18 ade6-210 leu1-32 arg3D his3D methods Py 3054 h-chp1::chp1CDΔ::ura4+ ura4D18 ade6-210 leu1-32 arg3D his3D
